Mainstay Medical Publishes 2016 Full Year Results and Business Update
In part four of our series, we look at how market conditions affect variable annuities. VAs may appear, on paper, to be a win-win, but the reality is more nuanced.
The insurer's variable annuities dipped 39% year-over-year in the second quarter, offering a glimpse into the power of big distributors like Fidelity.
Chugai's Anti-IL-31 Receptor A Humanized Monoclonal Antibody "nemolizumab (CIM331)" Global Phase II Study Data Published in The New England Journal of Medicine Online
Fixed indexed annuity sales are steadily gaining on those of variable annuities, thanks in large part to continued low interest rates.
Smart-beta strategies got their latest seal of approval in the form of a $100 million mandate from variable annuity giant Jackson National, which has added the DoubleLine Shiller Enhanced CAPE Fund to its menu of VA investment options.
ETFs could help solve the high costs that dog variable annuities.
Tight restrictions are placed on investment options in VAs with guaranteed income to reduce their risk. Returns have lagged as a result, frustrating advisers and investors.
Following record MetLife fine, regulator says VAs are now at the core of their focus: complex products marketed to seniors.
Properly assessing the viability of a variable annuity for a particular client entails considerably more than just adding it alongside a standard model portfolio.